biguanides has been researched along with incretins in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaudhuri, A; Dandona, P | 1 |
| Rabasseda, X | 1 |
| Kopecky, C | 1 |
| Giorda, CB; Gnavi, R; Marafetti, L; Nada, E; Tartaglino, B | 1 |
| Namba, M | 1 |
| Brzozowska, M; Iltchev, P; Iwańczuk, T; Jacyna, A; Marczak, M; Orlewska, E; Orlewska, K; Śliwczyński, A; Szymański, P; Wierzba, W | 1 |
4 review(s) available for biguanides and incretins
| Article | Year |
|---|---|
Effects of insulin and other antihyperglycaemic agents on lipid profiles of patients with diabetes.
Topics: Biguanides; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemic Agents; Incretins; Insulin; Randomized Controlled Trials as Topic; Sulfonylurea Compounds; Thiazolidinediones | 2011 |
Use of noninsulin antidiabetic medications in hospitalized patients.
Topics: Benzamides; Biguanides; Bromocriptine; Diabetes Mellitus; Dipeptidyl-Peptidase IV Inhibitors; Glycoside Hydrolase Inhibitors; Hospitalization; Humans; Hypoglycemia; Hypoglycemic Agents; Incretins; Islet Amyloid Polypeptide; Metformin; Sulfonylurea Compounds; Thiazolidinediones | 2013 |
A systematic review of acute pancreatitis as an adverse event of type 2 diabetes drugs: from hard facts to a balanced position.
Topics: Biguanides; Diabetes Mellitus, Type 2; Drug Administration Schedule; Humans; Hypoglycemic Agents; Incretins; Pancreatitis; Randomized Controlled Trials as Topic; Risk Factors; Sulfonylurea Compounds | 2014 |
[Programs for continuing medical education: a session; 7. Recent trends in treatment of diabetes mellitus].
Topics: Acarbose; Biguanides; Blood Glucose Self-Monitoring; Diabetes Mellitus; Dipeptidyl-Peptidase IV Inhibitors; Drug Administration Routes; Drug Design; Drug Therapy, Combination; Education, Medical, Continuing; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Incretins; Insulin; Pyrazines; Sitagliptin Phosphate; Triazoles | 2014 |
2 other study(ies) available for biguanides and incretins
| Article | Year |
|---|---|
A report from the 47th European Association for the Study of Diabetes annual meeting (September 12-16, 2011 - Lisbon, Portugal).
Topics: Biguanides; Diabetes Mellitus; Dipeptidyl-Peptidase IV Inhibitors; Enzyme Activators; Glucokinase; Humans; Hypoglycemic Agents; Incretins; Insulin; Islets of Langerhans Transplantation; Potassium Channel Blockers; Sodium-Phosphate Cotransporter Proteins; Sulfonylurea Compounds; Thiazolidinediones | 2011 |
Drug-class-specific changes in the volume and cost of antidiabetic medications in Poland between 2012 and 2015.
Topics: Biguanides; Diabetes Mellitus, Type 2; Health Expenditures; Humans; Hypoglycemic Agents; Incretins; Insulin; Insurance, Health; Poland; Reimbursement Mechanisms; Retrospective Studies; Thiazolidinediones | 2017 |